Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Common Stock | Options Exercise | $232K | +7.5K | +12.53% | $30.94 | 67.3K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $190K | +10K | +14.85% | $18.98 | 77.3K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $37K | +8.5K | +10.99% | $4.35* | 85.8K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $132K | +8.5K | +9.9% | $15.52 | 94.3K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $187K | +10K | +10.6% | $18.74 | 104K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $788K | +22.5K | +21.56% | $35.01 | 127K | Nov 8, 2021 | Direct | |
transaction | FCX | Common Stock | Sale | -$2.62M | -67K | -52.82% | $39.10 | 59.8K | Nov 8, 2021 | Direct | F4, F5 |
holding | FCX | Common Stock | 1.96K | Nov 8, 2021 | Through 401(k) Plan | F1 | |||||
holding | FCX | Common Stock | 3.79K | Nov 8, 2021 | By Spouse, through GRAT | ||||||
holding | FCX | Common Stock | 3.79K | Nov 8, 2021 | Through GRAT |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -22.5K | -81.82% | $0.00 | 5K | Nov 8, 2021 | Common Stock | 22.5K | $35.01 | Direct | F2 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -7.5K | -60% | $0.00 | 5K | Nov 8, 2021 | Common Stock | 7.5K | $30.94 | Direct | F2 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -8.5K | -18.09% | $0.00 | 38.5K | Nov 8, 2021 | Common Stock | 8.5K | $4.35 | Direct | F2 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -8.5K | -34% | $0.00 | 16.5K | Nov 8, 2021 | Common Stock | 8.5K | $15.52 | Direct | F2 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -10K | -28.57% | $0.00 | 25K | Nov 8, 2021 | Common Stock | 10K | $18.74 | Direct | F3 |
transaction | FCX | Options (right to buy) | Options Exercise | $0 | -10K | -50% | $0.00 | 10K | Nov 8, 2021 | Common Stock | 10K | $18.98 | Direct | F2 |
Id | Content |
---|---|
F1 | Based on plan statement as of December 31, 2020. |
F2 | 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof. |
F3 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |
F4 | Amount beneficially owned following the reported transactions includes 44,999 Common Stock Restricted Stock Units. |
F5 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $39.0300 - $39.1750. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |